The tech sector is abuzz with high hopes in AI’s potential to help the world beat back COVID-19. A veteran writer who’s been on the high-tech beat for years offers a reality check.

“This is one of the first times that artificial intelligence has been used to better define the different parts of a newborn's brain on an MRI," Canadian researchers explained March 26 in Frontiers in Neuroscience.

In a statement sent to Radiology Business, the college said it looks forward to “swift regulatory action” that will spell out how imaging practices and hospitals can apply for relief.

The Finnish maker of the Oura health-tracking finger ring is sponsoring a two-pronged, AI-aided COVID-19 study at the University of California, San Francisco (UCSF).

The fully digital modality can also offer insights into various neurodegenerative diseases, German researchers wrote. 

Physician-owned TRA Medical Imaging said the policy change will take effect immediately and apply across all of its managed locations. 

The European Society of Cardiology (ESC) is collecting first-hand accounts from healthcare workers all over the world who have been diagnosing, treating and caring for COVID-19 patients.

Hospitals are facing “massive losses” treating patients with COVID-19––even with higher reimbursement for service, according to a new study from Strata Decision.

Stanford researchers have developed a way to screen for lung cancer by combining next-gen molecular DNA quantification with machine learning. The experimental technique requires only a blood test and could, with refinement, replace low-dose CT scanning as an initial exam for longtime smokers.

Mortality rates for COVID-19 patients jump significantly when they have underlying cardiovascular disease (CVD) and myocardial injury, according to new research out of China.